Backhaus Sören J, Treiber Julia, Wolter Jan Sebastian, Kriechbaum Steffen D, Fischer Ulla, Schuster Andreas, Puntmann Valentina O, Nagel Eike, Sossalla Samuel, Rolf Andreas
Department of Cardiology, Campus Kerckhoff of the Justus-Liebig-University Giessen, Kerckhoff-Heart-Centre, Kerckhoff-Clinic, Benekestr. 2-8, 61231 Bad Nauheim, Germany.
German Center for Cardiovascular Research (DZHK), Partner Site Rhine-Main, Kerckhoff-Clinic, Benekestr. 2-8, 61231 Bad Nauheim, Germany.
Eur Heart J Open. 2025 Aug 20;5(5):oeaf109. doi: 10.1093/ehjopen/oeaf109. eCollection 2025 Sep.
Deformation imaging remains underused for cardiovascular risk assessment. As tissue characterization has now been recognized as an additional assessment tool, we sought to investigate the significance of native T1 and extracellular volume (ECV) in an unselected clinical routine population.
The single-centre, prospective cardiovascular magnetic resonance (CMR) registry included patients referred for clinical CMR. Left ventricle global longitudinal strain (GLS) was evaluated in long-axis views. Native T1 and ECV were assessed on septal, basal, or midventricular short-axis positions. Follow-up was conducted for primary (all-cause mortality and heart failure hospitalization) and secondary (all-cause mortality, hospitalized angina, and myocardial infarction) endpoints. The final population consisted of = 1633 patients who met primary ( = 68) and secondary ( = 90) endpoints during the median follow-up of 395 days. A 10-ms T1 increase was associated with a hazard ratio (HR) of 1.11 [95% confidence interval (CI) 1.07-1.15, < 0.001] for the primary endpoint independent of ECV ( = 0.738). T1 (HR 1.07, 95% CI 1.03-1.11, = 0.001) but not ECV ( = 0.674) was an independent predictor for the primary endpoint after correction for common risk factors including age, New York Heart Association class, biomarker NT-proBNP/glomerular filtration rate, and GLS. After dichotomization at the median of 1126 ms, T1 added incremental value for primary endpoint prediction on Kaplan-Meier plots in patients with left ventricular ejection fraction above/below ( = 0.019/0.017) the median of 55% and GLS above/below ( = 0.019/0.041) the median of -16.4%.
Native T1 was found to be an independent risk predictor beyond GLS as well as common clinical risk factors. This may justify the use of non-contrast CMR protocols in selected patients if contrast application is contraindicated.
形变成像在心血管风险评估中的应用仍未得到充分利用。由于组织特征现在已被视为一种额外的评估工具,我们试图研究在未经选择的临床常规人群中,固有T1和细胞外容积(ECV)的意义。
单中心前瞻性心血管磁共振(CMR)登记研究纳入了因临床CMR检查而转诊的患者。在长轴视图中评估左心室整体纵向应变(GLS)。在室间隔、心底或心室中部短轴位置评估固有T1和ECV。对主要终点(全因死亡率和心力衰竭住院)和次要终点(全因死亡率、住院性心绞痛和心肌梗死)进行随访。最终人群包括1633例患者,在395天的中位随访期内达到主要终点(68例)和次要终点(90例)。固有T1增加10毫秒与主要终点的风险比(HR)为1.11 [95%置信区间(CI)1.07 - 1.15,P < 0.001],与ECV无关(P = 0.738)。在校正包括年龄、纽约心脏协会分级、生物标志物NT - proBNP/肾小球滤过率和GLS等常见风险因素后,T1(HR 1.07,95% CI 1.03 - 1.11,P = 0.001)而非ECV(P = 0.674)是主要终点的独立预测因素。在1126毫秒的中位数处进行二分法后,对于左心室射血分数高于/低于(P = 0.019/0.017)中位数55%且GLS高于/低于(P = 0.019/0.041)中位数 - 16.4%的患者,T1在Kaplan - Meier图上为主要终点预测增加了增量价值。
发现固有T1是除GLS以及常见临床风险因素之外的独立风险预测因素。如果造影剂应用存在禁忌,这可能证明在特定患者中使用非造影CMR方案是合理的。